Alzheimer's patients face bigger challenges than drug controversy
The bungled approval process for the drug Aduhelm diverts attention from the lack of critical support for Alzheimers patients and their families.
United States Department Of Health Human Services Program For Positive Drug Administration University Of Michigan
Source: azcentral.com